Volume No. :   7

Issue No. :  1

Year :  2017

ISSN Print :  2231-5640

ISSN Online :  2231-5659


Registration

Allready Registrered
Click to Login

Gelucire: An Optional Innovative Tool for both Sustained and Fast Release of Drugs in Treating Diabetes Mellitus Type II Disease



Address:   Harikrishnan.V1, Sreejith. M2, Elthose. M.J1, Akash Marathakam3
1Mookamabika College of Pharmaceutical Science and Research, Muvatupuzha Kerala, India
2Nazareth College of Pharmacy, Thiruvalla, Kerala, India
3National College of Pharmacy Kozhikode, Kozhikode, Kerala, India
*Corresponding Author
DOI No: 10.5958/2231-5659.2017.00006.6

ABSTRACT:
Gelucire is the group of vehicle got from blends of mono-, di-and tri-glycerides with PEG esters of unsaturated fats. They have a wide assortment of utilization in pharmaceutical definitions. These are utilized as a part of the arrangement of quick release and maintained release of drug in sustained manner. Keeping in mind the end goal to build the bioavailability of medications, the residence time of the orally controlled dose frame in the upper GIT should be drawn out. The principle ways to deal with drawing out the gastric residence time of pharmaceutical dosage form incorporates thickness control conveyance framework, which drift on gastric liquid and a resource for treat Diabetes sort II. Gastro retentive strong scattering could be accomplished of ineffectively solvent medication Glibenclamide with the assistance of polyethylene glycol and Gelucire 50/13. Then again managed discharge gastroretentive multiparticulates of metformin hydrochloride could be accomplished utilizing Gelucire 39/01 and 43/01 grades. Further both details can be investigated individual and also in mix for enhanced bioavailability by their pharmacokinetic and pharmacodynamic assessment in wistar rats.
KEYWORDS:
Gelucire, Metformin, Glibenclamide, Solid dispersion.
Cite:
Harikrishnan.V, Sreejith. M, Elthose. M.J, Akash Marathakam. Gelucire: An Optional Innovative Tool for both Sustained and Fast Release of Drugs in Treating Diabetes Mellitus Type II Disease. Asian J. Res. Pharm. Sci. 2017; 7(1): 33-37.
[View HTML]     



Visitor's No. :   41912